Objectives: To explore the mismatch between functional bladder capacity and nocturnal urine production, and to study the pathophysiology of an increased nocturnal urine production in older patients with urinary incontinence. Methods: The present prospective observational study included adults aged ≥65 years with urinary incontinence. Participants completed questionnaires, frequency volume charts and renal function profiles. The nocturnal lower urinary tract symptom index was defined as nocturnal urine output/maximum voided volume; the nocturnal polyuria index as nocturnal/24 h urine output. Results: The median age (n = 95) was 74 years (69-79), 87% were women and 73% had nocturnal lower urinary tract symptoms (nocturnal urinary incontinence or nocturia ≥2). Participants with nocturnal lower urinary tract symptoms had a significantly higher nocturnal urine output (809 mL vs 650 mL; P = 0.001) and no significant difference in maximum voided volume (350 mL vs 437 mL; P = 0.079) compared with participants without nocturnal lower urinary tract symptoms. Participants (nocturnal polyuria index >33% [n = 56], nocturnal polyuria index >40% [n = 42], nocturnal lower urinary tract symptom index >1.87 [n = 51]) showed higher night-time diuresis rates, free water and sodium clearance compared with during the daytime. Controls (nocturnal polyuria index ≤33% [n = 26], nocturnal polyuria index ≤40% [n = 40], nocturnal lower urinary tract symptom index ≤1.87 [n = 44]) had no circadian rhythm in their diuresis rate or sodium clearance, but more nocturnal free water clearance compared with during the daytime. Conclusions: The majority of older adults with urinary incontinence present nocturnal lower urinary tract symptoms. An increased nocturnal sodium diuresis seems to be the only mechanism differentiating patients with nocturnal lower urinary tract symptoms from controls.
Introduction
Nocturia and NUI are highly prevalent N-LUTSs in older people. [1] [2] [3] [4] Nocturia is reported in 70-92% of men and women aged >60 years, and NUI in 12-24%. 5, 6 These symptoms increase the risk of fall accidents, and reduce general well-being, sleep quality and overall health.
limited discriminative value to diagnose NP as a cause of nocturia, which is one of the arguments in the ongoing debate regarding NP definitions. 17 Although N-LUTS are highly prevalent in older adults, and it seems logical that these symptoms result from a mismatch between FBC and NUP, little is known about the link between FBC, NUP and N-LUTS. Therefore, the objective of the present study was to explore the mismatch between FBC and NUP, and to study the pathophysiology of an increased NUP in older patients with UI.
Methods

Sampling strategy
The present study was a prospective, observational study carried out in Ghent University Hospital between February 2014 and October 2016. After a normal cognitive screening (Mini-Cog), all persons aged ≥65 years who consulted our tertiary referral center with complaints of UI were asked to participate. There were no specific exclusion criteria.
Data collection
Study protocol was completed ambulatory (n = 29) or during hospitalization (n = 66). Demographics, medical history and medication use were derived from the medical record, blood pressure measurement was carried out after the first consultation, and participants completed validated questionnaires to assess independence in activities of daily living (Katzindex), 18 risk factors for falls (Stratify), 19 frailty (Tilburg Frailty Indicator) 20 and LUTSs (ICIQ-MLUTS  21 or ICIQ-FLUTS   22 ). Hypertension was defined as a systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg or intake of antihypertensive drugs.
All participants completed a FVC during 24 h (n = 69), 48 h (n = 4) or 72 h (n = 22), for which they had to register time and volume of voided volumes and incontinence weight, and time of going to sleep and waking up in the morning. Missing values were only corrected if they concerned one voided volume during the daytime on condition that there were at least four other daytime voids and that it was not the first morning void. In that case, an average of the other daytime voids was calculated for the missing value. Parameters derived from FVCs were used to:objectify the presence of N-LUTS, which was defined as NUI or nocturia ≥2; and calculate the NP i and N-LUTS i (modified nocturia index 23 that includes UI):
As recommended by the ICS, all participants with global polyuria (urine output >40 mL/kg/24 h) were excluded in calculations with the NP i . 15 Cut-off values for the NP i and the N-LUTS i (see section Statistical analysis) were used to assign participants to subgroups: 1 Method 1 (NP i , exclusion of global polyuria):
• cases: NP i >33% (n = 56)
• controls: NP i ≤ 33% (n = 26) 2 Method 2 (NP i , exclusion of global polyuria):
• cases: NP i >40% (n = 42)
• controls: NP i ≤40% (n = 40) 3 Method 3 (N-LUTS i ):
• cases: N-LUTS i >1.87 (n = 51)
• controls: N-LUTS i ≤1.87 (n = 44)
To obtain RFPs, a blood sample was taken and a 24 h urine collection was carried out before or after completion of the FVC. Therefore, participants had to void at fixed time-points every 3 h to register voided volumes and urine loss, and to take a urine sample to determine sodium, creatinine and osmolality. For all interim micturitions, voided volume and amount of urine loss was registered. 13 The diuresis rate was calculated based on urine output, and thus including both voided volumes and incontinence weight. Renal clearance of free water, solutes and sodium was calculated for the five daytime (10.00 hours, 13.00 hours, 16.00 hours, 19.00 hours, 22.00 hours) and three night-time urine samples (01.00 hours, 04.00 hours, 07.00 hours):
Ethical approval was obtained from the Ghent University Hospital ethics committee (EC/2013/950). The Declaration of Helsinki was followed and all participants gave written informed consent.
Statistical analysis
The median, interquartile range and frequency were recorded as descriptive parameters. Differences between groups were assessed using the Fisher's exact test ( 
Results
Total study population
The median age of the 95 enrolled participants was 74 years (interquartile range 69-79 years), and 87% were women. The great majority (97%) were community-dwelling persons; three participants were nursing home residents. Hypertension was found in 67 (71%) participants. Venous insufficiency was reported by 36 (38%) participants, diabetes mellitus by 14 (15%) and heart failure by 11 (12%). Beta-blockers were the most commonly used medication (30%), followed by diuretics (18%) and calcium channel blockers (16%; Table 1 ). Included participants had a Katz score indicating that activities of daily living were moderately impaired to fully preserved, and low frailty scores. Risk of falling was low in 15%, moderate in 50% and high in 35% of participants. Analysis of FVCs showed that the majority (96%) showed either NUI or nocturia ≥1, and that 73% showed either NUI or nocturia ≥2 (N-LUTS). Nocturia ≥1 was reported in 91% (n = 86), nocturia ≥2 in 51% (n = 48) and NUI in 51%
(n = 48) of participants. Just 4% (n = 4) did not have any N-LUTS (Table 2) .
N-LUTS (n = 69) versus no N-LUTS (n = 26): General characteristics
Participants with N-LUTS were significantly older than those without N-LUTS. Both groups showed no significant difference in sex, body mass index, medication use and comorbidities (Table 1) . Comparing the results of the questionnaires between participants with and without N-LUTS showed a higher prevalence of moderate and high risk of falling in the group with N-LUTS. Women with N-LUTS had higher scores on the filling and incontinence subscales of the ICIQ-FLUTS questionnaire (Table 2) .
N-LUTS (n = 69) versus no N-LUTS (n = 26): A mismatch between FBC and NUP?
A significant correlation between MVV and nocturnal urine output was found both in the group with (r s = 587; P < 0.001) and without (r s = 0.578; P = 0.002) N-LUTS ( Fig. 1 ). Based on FVCs, participants with N-LUTS had a significantly higher nocturnal urine output compared with participants without N-LUTS, whereas 24-h urine output and MVV were not different between both groups (Table 2 ). In Table 1 Demographic data, medication use and medical history in the total group (n = 95) and in participants with (n = 69) and without (n = 26) nocturnal LUTS accordance with these findings, logistic regression highlighted the association between the presence of N-LUTS and nocturnal urine output (OR 1.003, 95% CI 1.001-1.005; P = 0.001), whereas the association with MVV was not significant (OR 0.998, 95% CI 0.995-1.001; P = 0.132).
Evaluation of N-LUTS and its underlying pathophysiology: NP i and N-LUTS i
ROC analysis to discriminate between participants with and without N-LUTS showed an AUC of 89% for the N-LUTS i , with a cut-off value of 1.87 corresponding to a sensitivity of 74% and specificity of 96%. As the most widely used NP definition is based on a NP i >33%, ROC analysis was also carried out with the NP i (AUC 76%). A cut-off value of 40% corresponded to a sensitivity of 67% and specificity of 88% (Table 3) .
Pathophysiology of N-LUTS: Differences in water and sodium diuresis? (Table 4) . Regardless of the definition used, cases showed significantly higher values for night-time diuresis rate, free water and sodium clearance compared with daytime. In the controls, no significant circadian rhythm in the diuresis rate and sodium clearance was found, and controls defined as a NP i ≤33% or NP i ≤40% showed a significantly higher nocturnal free water clearance compared with daytime (Table 5) . 
Discussion
We found that 96% of adults aged ≥65 years, who consulted for complaints of UI, had either NUI or nocturia ≥1. This could be explained by the fact that aging is usually accompanied by changes in circadian rhythms of the bladder and the kidney, which leads to N-LUTS once NUP exceeds FBC. 1, 9 Studies in nursing home residents showed that a NUP >625 mL was a risk factor for UI rather than nocturia, 24 and that NUI was associated with higher volumes per incontinence episode compared with daytime UI, 2 which was linked to a lower quality of life. 25 Although N-LUTS are often co-existing symptoms in patients presenting across different medical departments, patients and physicians look upon it as merely part of the aging process or assume that nothing can be done. However, the potentially harmful consequences show that active screening is meaningful, and that a comprehensive assessment addressing the underlying pathophysiology, comorbidities, functional status and medication use might be valuable to deliver individualized treatment recommendations. 3, 26 The present findings highlighted the role of NUP in the development of N-LUTS in older adults. The observation that both participants with and without N-LUTS had a positive correlation between nocturnal urine output and MVV could indicate that FBC adapts to NUP or vice versa, and warrants further exploration. The nocturia index, used to objectify mismatches between FBC and NUP leading to nocturia, was not applicable in participants with UI, and therefore, we developed the N-LUTS i for research purposes. 23 A cut-off value of 1.87 showed a sensitivity of 74% and a specificity of 96% to detect N-LUTS (AUC 89%; P < 0.001). As the ICS definition for NP (NP i >33%) is under discussion because of its limited discriminative value for nocturia, and as we focused on N-LUTS and not only on nocturia, ROC analysis to identify N-LUTS was also applied for the NP i (AUC 76%; P < 0.001). We found a sensitivity of 67% and specificity of 88%, with a cut-off value of 40%, whereas the commonly used value of 33% had a higher sensitivity (79%) and lower specificity (58%). These cut-off values served as an approach to assess N-LUTS in a research setting, and might encourage researchers to further unravel the pathophysiology of N-LUTS, as this is an underinvestigated topic in geriatric and urological research that is relevant for clinical practice.
Regardless of what definition is chosen to define NP or N-LUTS, the mechanisms underlying NUP encompass circadian disorders in water diuresis (vasopressin deficiency), sodium diuresis (sleep apnea, reabsorption of peripheral edema) or a combination. Those NP subtypes can be distinguished using RFPs, as described in previous studies in children and adults. 13, 14 The current study found that an increase in nocturnal sodium diuresis was the driving force of N-LUTS in older patients. The reason for that was the observation that, compared with during the daytime, an increase in nocturnal water diuresis was found in cases (NP i >33%; NP i >40%; N-LUTS i >1.8) and controls (NP i ≤33%/NP i ≤40%). In contrast, nocturnal sodium diuresis was only higher in the cases, and therefore the only pathophysiological mechanism discriminating cases from controls. The current study showed that patients with N-LUTS differed from controls by the increased nocturnal sodium diuresis in addition to the increased nocturnal water diuresis that seemed to be predominant in all older participants, regardless of the presence of N-LUTS. These findings suggest that treatment of N-LUTS in older patients should target the increased nocturnal sodium diuresis regardless of whether it is combined with a treatment for increased nocturnal water diuresis in order to reduce NUP:
An abnormal circadian rhythm in vasopressin has been described in children with nocturnal enuresis and adults with nocturia, and can be treated with the vasopressin analog, desmopressin. 27 Studies in older patients showed that doses <0.2 mg are safe and effective if patients are closely followed up because of the risk of hyponatremia, particularly in the case of non-restricted fluid intake. 28 Also, an effect on NUI has been described. 29 We hypothesize that the increased nocturnal sodium diuresis might be the result of reabsorption of peripheral edema, non-dipping hypertension or an increased sodium intake. Consequently, compression stockings, adequate control of blood pressure or a low-sodium diet might be helpful to target the increased nocturnal sodium diuresis. 27, 30, 31 Also, administration of diuretics 6 h before bedtime can stimulate the excretion of patients' sodium load during the daytime, so that it is processed by the time patients go to bed in the evening. Previous studies in older adults showed that furosemide compared with a placebo led to a significant decrease in night-time frequency and voided volumes. Also, the combination of furosemide and desmopressin showed a significant decrease in night-time frequency and NUP compared with a placebo. 27 Because research in the field of N-LUTS in older adults is limited, the information gained by the current study is innovative, as we found that older patients with N-LUTS differed (24) 7 (18) 0.303
14 (28) 3 (7) 0.262
No. daytime voids Data are presented as median (interquartile range) or frequency (%). from controls because of the increased nocturnal sodium diuresis. Therefore, the present findings have to be regarded as an essential step toward future studies to study the prevalence and link between UI and N-LUTS, and to unravel the pathophysiology of N-LUTS in more detail. Also, randomized controlled trials to determine effective treatment strategies (compression stockings, blood pressure control, sodium restricting diet, different types of diuretics, desmopressin and all combinations) in those older patients who are typically more vulnerable to drug side-effects are needed to optimize management of these patients in clinical practice. Although the study sample represented a population seen in clinical practice, the present study had limitations. We evaluated mainly women who consulted for complaints of UI, and 73% of participants collected their FVC during only 24 h. However, 69% of them were hospitalized, so all measurements were carried out by nurses. Although patients had to complain about UI to be included, we only identified NUI in 51% of participants during the study duration. We also found that patients with N-LUTS had a higher risk of falling compared with controls, but the collected data about comorbidities, timing and type of medication intake, risk of falling, and frailty were not taken into account for the analysis of circadian rhythms of water and sodium diuresis. Therefore, larger study samples are required to evaluate the effect of these aspects on the prevalence, pathophysiology, consequences and treatment of N-LUTS in older patients.
In conclusion, N-LUTS were found in the great majority of older adults with UI. An increased nocturnal water diuresis compared with during the daytime was predominant in all participants, regardless of the presence of N-LUTS. An increased nocturnal sodium diuresis compared with during the daytime was the only mechanism differentiating patients with N-LUTS from controls. Future studies need to evaluate the therapeutic consequences of these findings.
